PureTech Health (LON:PRTC) Share Price Passes Below 50-Day Moving Average – Here’s Why

Shares of PureTech Health plc (LON:PRTC) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 140.42 ($1.81) and traded as low as GBX 128.20 ($1.65). PureTech Health shares last traded at GBX 131 ($1.69), with a volume of 186,057 shares changing hands.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group reissued a “buy” rating and set a GBX 455 ($5.86) price objective on shares of PureTech Health in a research note on Monday, December 16th.

PureTech Health Price Performance

The company has a debt-to-equity ratio of 45.82, a current ratio of 3.68 and a quick ratio of 2.51. The firm has a market capitalization of £382.08 million, a PE ratio of -5.22 and a beta of 1.02. The company has a 50-day moving average price of GBX 139.83 and a 200-day moving average price of GBX 149.92.

PureTech Health Company Profile

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.